Is IMV or VYM a better dividend investment in 2026?

IMV currently yields 243.16% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: IMV offers higher current income.

What is the dividend yield difference between IMV and VYM?

IMV has a forward dividend yield of 243.16% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 240.75 percentage points.

Home › Compare › IMV vs VYM

IMV vs VYM: Dividend Comparison 2026

IMV yields 243.16% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMV wins by $387.15M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMV

● Live price

243.16%

Share price

$0.82

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$387.18M

Annual income

$214,028,196.67

Full IMV calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — IMV vs VYM

📍 IMV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMV	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMV + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMV pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMV

Annual income on $10K today (after 15% tax)

$20,668.69/yr

After 10yr DRIP, annual income (after tax)

$181,923,967.17/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, IMV beats the other by $181,923,730.40/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMV + VYM for your $10,000?

IMV: 50%VYM: 50%

100% VYM50/50100% IMV

Portfolio after 10yr

$193.60M

Annual income

$107,014,237.60/yr

Blended yield

55.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IMV right now

IMV

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-11.6

Piotroski

1/9

VYM

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMV buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMVVYM

Forward yield	243.16% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$387.18M ✓	$27.8K
Annual income after 10y	$214,028,196.67 ✓	$278.55
Total dividends collected	$368.51M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IMV vs VYM ($10,000, DRIP)

Year	IMV Portfolio	IMV Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$35,016	$24,316.11	$11,151	$241.44	+$23.9K → IMV
2	$117,043	$79,575.28	$12,413	$246.79	+$104.6K → IMV
3	$373,818	$248,582.30	$13,794	$251.79	+$360.0K → IMV
4	$1,141,983	$741,998.00	$15,306	$256.47	+$1.13M → IMV
5	$3,340,374	$2,118,452.03	$16,960	$260.84	+$3.32M → IMV
6	$9,365,423	$5,791,222.89	$18,768	$264.92	+$9.35M → IMV
7	$25,195,657	$15,174,654.72	$20,745	$268.71	+$25.17M → IMV
8	$65,112,761	$38,153,408.06	$22,905	$272.24	+$65.09M → IMV
9	$161,819,518	$92,148,863.05	$25,265	$275.51	+$161.79M → IMV
10	$387,175,081	$214,028,196.67	$27,842	$278.55	+$387.15M → IMV

IMV vs VYM: Complete Analysis 2026

IMV — Stock

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Full IMV Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this IMV vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMV vs SCHD IMV vs JEPI IMV vs O IMV vs KO IMV vs MAIN IMV vs VIG IMV vs DGRO IMV vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.